Renal function and mortality following cardiac resynchronization therapy

European Heart Journal

Volumn 32, Issue 2, 2011, Pages 184-190

  Lin, Grace ^a   Gersh, Bernard J ^a   Greene, Eddie L ^a   Redfield, Margaret M ^a   Hayes, David L ^a   Brady, Peter A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac resynchronization therapy; Chronic kidney disease; Heart failure; Mortality

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DIALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HUMAN; IMPLANTATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL;

AGED; BIOLOGICAL MARKERS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIO-RENAL SYNDROME; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 78651497651     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq403     Document Type: Article

References (30)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
2. Bristow M, Saxon L, Boehmer J, Krueger S, Kass D, DeMarco T, Carson P, DiCarlo L, DeMets D, White B, DeVries D, Feldman A. Cardiac-resynchronization therapy with or without an implantable cardioverter defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
3. Cleland J, Daubert J, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. (Pubitemid 40517094)
4. Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter- defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-2868.
5. Chung ES, Leon AR, Tavazzi L, Sun J.-P, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu C-M, Gorcsan J III, St John Sutton M, De Sutter J, Murillo J. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008;117:2608-2616.
6. Cuculich PS, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 2007;30:207-213.
7. Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defi- brillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006;17:940-943.
8. Hreybe H, Razak E, Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2007;30:1091-1095.
9. Shalaby A, El-Saed A, Voigt A, Albany C, Saba S. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy. Pacing Clin Electrophysiol 2008;31:575-579.
10. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-689.
11. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-962.
12. Marenzi G, Moltrasio M, Assanelli E, Lauri G, Marana I, Grazi M, Rubino M, De Metrio M, Veglia F, Bartorelli AL. Impact of cardiac and renal dysfunction on in hospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 2007;153:755-762.
13. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004;43:61-67. (Pubitemid 38045917)
14. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal Insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001;134:629-636.
15. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJV, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, De Zeeuw D, Pocock S, van Veldhuisen DJ. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113:671-678.
16. Levey AS, Coresh J, Balk E, Kausz A, Levin A, Steffes M, Hogg R, Perrone R, Lau J, Eknoyan G. National kidney foundation practice guidelines for chronic kidney disease: evaluation classification, risk stratification. Ann Intern Med 2003;139: 137-147.
17. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult us population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
18. K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classi- fication, and stratification kidney disease outcome quality initiative. Am J Kidney Dis 2002;39:S1-246.
19. Cockgroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
20. Hillege HL, Girbes ARJ, De Kam PJ, Boomsma F, De Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen J. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-210.
21. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-1786.
22. Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Pina IL, Felker GM, Adams KF Jr, Califf RM, Gheorghiade M. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Study. Circulation 2005;111:2454-2460.
23. Kumar S, Rubin S, Mather PJ, Whellan DJ. Hyponatremia and vasopressin antagonism in congestive heart failure. Clin Cardiol 2007;30:546-551.
24. Silverberg D, Wexler D, Blum M, Iaina A. The cardio-renal syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol 2003;60: S93-S102.
25. O'Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh TA. The modification of diet in renal disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail 2006;8:63-67.
26. Cowburn PJ, Patel H, Pipes RR, Parker JD. Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity. Eur J Heart Fail 2005;7:899-903.
27. Linde C, Abraham WT, Gold MR, St. John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-1843.
28. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NAM III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338.
29. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defi- brillation in Heart Failure (COMPANION) trial. Circulation 2006;114:2766-2772.
30. Lin G, Rea RF, Hammill SC, Hayes DL, Brady PA. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices. Heart 2008;94:186-190.